Options
CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief Report
Journal
Journal of Thoracic Oncology
Journal Volume
18
Journal Issue
5
Start Page
650-656
ISSN
1556-0864
Date Issued
2023-05
Author(s)
Dong-Wan Kim
Sang-We Kim
D. Ross Camidge
Catherine A. Shu
Kristen A. Marrone
Xiuning Le
Collin M. Blakely
Keunchil Park
Sandip Pravin Patel
Gozde Kar
Zachary A. Cooper
Ramin Samadani
Michael Pluta
Rakesh Kumar
Suresh Ramalingam
SDGs
Publisher
Elsevier BV
Type
journal-article